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Summary Introduction
Deletions of the distal short arm of chromosome 1 Deletion of the distal band(s) of some chromosomes
(1p36) represent a common, newly delineated deletion has long been recognized as the cause of certain ge-
syndrome, characterized by moderate to severe psycho- netic disorders with congenital abnormalities and
motor retardation, seizures, growth delay, and dysmor- mental retardation; examples include Wolf-Hirsch-
phic features. Previous cytogenetic underascertainment horn syndrome (4p monosomy) (Wolf et al. 1965;
of this chromosomal deletion has made it difﬁcult to Leao et al. 1967) and cri-du-chat syndrome (5p mono-
characterize the clinical and molecular aspects of the somy) (Lejeune et al. 1963), although, by high-resolu-
syndrome. Recent advances in cytogenetic technology, tion chromosomal banding techniques, distal dele-
particularly FISH, have greatly improved the ability to tions for virtually all chromosomes have been
identify 1p36 deletions and have allowed a clearer deﬁ- identiﬁed in patients. Deletion of the distal short arm
nition of the clinical phenotype and molecular character- of chromosome 1 (1p36 deletion) is a recently identi-
istics of this syndrome. We have identiﬁed 14 patients ﬁed chromosomal syndrome that we believe has been
with chromosome 1p36 deletions and have assessed the previously underascertained by cytogenetic analysis.
frequency of each phenotypic feature and clinical mani- This may be due to the difﬁculty in clearly visualizing
festation in the 13 patients with pure 1p36 deletions. by conventional cytogenetics the light-staining G-neg-
The physical extent and parental origin of each deletion ative bands constituting the 1p36 region.
were determined by use of FISH probes on cytogenetic Partial monosomy of chromosome 1p36 was ﬁrst
preparations and by analysis of polymorphic DNA reported in 1980 in an infant who had inherited an
markers in the patients and their available parents. Clini- unbalanced-translocation product from a parent who
cal examinations revealed that the most common fea- carried a balanced 1;15 translocation (Hain et al.
tures and medical problems in patients with this deletion 1980). This child, as well as several subsequently re-
syndrome include large anterior fontanelle (100%), mo- ported individuals (Desangles et al. 1983; Barbi et al.
tor delay/hypotonia (92%), moderate to severe mental 1992; Reish et al. 1995), had partial monosomy 1p36
retardation (92%), growth delay (85%), pointed chin in addition to partial trisomy of another chromosomal
(80%), eye/vision problems (75%), seizures (72%), ﬂat region (double-segmental imbalance), because of in-
nasal bridge (65%), clinodactyly and/or short ﬁfth ﬁn- heritance of unbalanced-translocation products from
ger(s) (64%), low-set ear(s) (59%), ear asymmetry a parent. These patients were easily identiﬁed cytoge-
(57%), hearing deﬁcits (56%), abusive behavior (56%), netically because of their other segmental imbalance.
thickened ear helices (53%), and deep-set eyes (50%). However, delineation of the clinical effects of 1p36
FISH and DNA polymorphism analysis showed that monosomy, separate from the effects of the other
there is no uniform region of deletion but, rather, a chromosomal imbalances, was not possible. Other pa-
spectrum of different deletion sizes with a commonmini- tients with de novo–derivative chromosomes involv-
mal region of deletion overlap. ing deletion of distal 1p have also been described,
but, similarly, they are not ideal for delineation of the
features of the 1p36 deletion syndrome, because of
additional chromosomal imbalance (Yunis et al. 1981;
Steele et al. 1984; Reish et al. 1995). Since 1987, 14Received March 4, 1997; accepted for publication June 6, 1997.
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et al. 1988; Wargowski et al. 1991; Wexler et al. 1991; Texas Medical School) were identiﬁed as having 1p36
deletions, by G-banded chromosome analysis per-Keppler-Noreuil et al. 1995; Reish et al. 1995; Sandlin
et al. 1995). formed on peripheral blood lymphocytes; 1 additional
patient was ascertained prenatally, by chromosomeIn delineating the clinical features of 1p36 deletions,
previous clinical summaries have not conﬁned their analysis performed on amniocytes, and was conﬁrmed
postnatally, by analysis of peripheral blood lympho-characterization of the deletion phenotype to patients
with pure 1p36 deletions (Keppler-Noreuil et al. cytes, to have a 1p36 deletion. Blood samples were
subsequently collected from all 14 patients and their1995; Reish et al. 1995; Sandlin et al. 1995); they
have included the phenotypic features and clinical available parents, and lymphoblastoid cell lines were
established by methods described elsewhere (Watt andmanifestations of patients with double-segmental im-
balances. This approach may provide a general gestalt Stephen 1986). The protocols were approved by the
institutional review board of Baylor College of Medi-of the physical features and medical problems associ-
ated with 1p36 deletions; however, assessment of the cine, and informed consent was obtained from the
parents or guardians of all patients.frequency of each particular phenotypic feature and
deﬁnition of the isolated 1p36 deletion phenotype Thorough clinical characterization of the patients
was performed after the cytogenetic diagnosis was es-have been confounded by the effects of other chromo-
somal imbalance. tablished, in order to document features for table 1;
all of the features listed within table 1 were part of aHerein we describe the clinical features of 13 pa-
tients with isolated deletion of the distal short arm of checklist utilized by the examiner. The checklist was
compiled on the basis of features reported previouslychromosome 1. In order to deﬁne the clinical pheno-
type of patients with this chromosomal deletion syn- in the literature, as well as on the basis of features
observed in our patients. All patients presented in thisdrome, we compare the phenotypes of our patients
with those of four patients previously described with report were examined by one of the authors (patients
2–14 were examined by S.K.S., and patient 1 waspresumedly pure 1p36 deletions (Keppler-Noreuil et
al. 1995; Reish et al. 1995) and with that of one pa- examined by F.G.). Eight of the 14 patients have been
examined (by S.K.S.) on more than one occasion, intient with a 1p35 deletion (Wenger et al. 1988). By
excluding the patients with double-segmental imbal- order to document any changes in their features.
ance, we can assess the variability of features that
FISHappear speciﬁc to patients with the 1p36 deletion.
It has been suggested that the phenotypic variability Metaphase chromosome preparations of peripheral
blood lymphocytes from the 14 patients and availableamong patients with the 1p36 deletion syndrome, par-
ticularly with regard to growth, may be due to the parents were studied by FISH using four probes mapping
to 1p36.3: p1-79 (ATCC), p58 (Oncor), 1A9, andparental origin of the deletion and to the effects of
imprinted genes (Wargowski et al. 1991; Keppler- 13P11. A FISH probe mapping to the centromere of
chromosome 1, D1Z5 (Oncor), was used as a control.Noreuil et al. 1995). Conversely, phenotypic variabil-
ity may be due to submicroscopic differences in the Probe p1-79 (also known as ‘‘D1Z2’’) binds to a distal
1p hypervariable repeated sequence (Buroker et al.physical extent of each deletion resulting in the loss
of different contiguous dosage-sensitive genes, or due 1987). Probe p58 (also known as ‘‘CDC2L1’’ or
‘‘PITSLRE’’) identiﬁes a cell cycle–regulated kinase geneto the unmasking of certain recessive alleles. In order
to investigate these possibilities, our 13 patients with with homology to human CDC2 (Bunnell et al. 1990).
BAC probe 1A9 (Shizuya et al. 1992) and PAC probepure 1p36 deletions, as well as 1 patient with distal
1p monosomy in conjunction with minimal distal 22q 13P11 (Ning et al. 1996) are clones of chromosome
1–speciﬁc sequences that contain the DNA polymor-trisomy, have been studied with DNA polymorphisms
and FISH, to determine the parental origin of each phisms D1S214 and D1S1615, respectively. All FISH
analyses were performed according to methods de-deleted chromosome, as well as to deﬁne the extent
of each deletion interval. The results indicate that no scribed elsewhere (Shaffer et al. 1994).
parent-of-origin effect is obvious and that the physical
Polymorphic Marker Analysisextent of deletions of 1p36 is quite variable.
Total cellular DNA was prepared from either pe-
ripheral blood lymphocytes or lymphoblastoid cellSubjects, Material, and Methods
lines (Spence et al. 1987). As many as 12 dinucleotide
Patients and Cell Lines or tetranucleotide polymorphisms located in chromo-
some 1p36 were analyzed on the 14 patients and theirDuring 1993–96, 13 patients referred, for cytoge-
netic studies, to the Kleberg Cytogenetics Laboratory available parents (Shaffer et al. 1993). To establish
which polymorphic loci were deleted, alleles were(Baylor College of Medicine) and to the Hermann
Hospital Cytogenetics Laboratory (The University of compared between each patient and available parents
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Table 1
Clinical Features of Pure 1p36 Deletion Patients
Report Previous Reports
Feature (n Å 13) (n Å 5) Total (%)
Clinical:
Growth delay (postnatal) 8/8 3/5 11/13 (85)
Normal prepubertal height (at age ú1 year) 0/7 2/5 2/12 (17)
Precocious puberty 2/3 1/1 3/4 (75)
Obesity 1/8 1/5 2/13 (15)
Motor delay/hypotonia 8/8 4/5 12/13 (92)
Mental retardation (moderate-severe) 7/8 5/5 12/13 (92)
Abusive behaviora 3/7 2/2 5/9 (56)
Seizuresb 9/13 4/5 13/18 (72)
Hearing deﬁcits 4/8 1/1 5/9 (56)
Eye/vision problems 6/8 3/4 9/12 (75)
Infant feeding problems 7/13 1/4 8/17 (47)
Dysmorphic:
Microcephaly (postnatal) 4/9 1/4 5/13 (38)
Brachycephaly 5/13 1/1 6/14 (43)
Large anterior fontanelle 8/8 3/3 11/11 (100)
Low anterior hairline 5/13 0/0 5/13 (38)
Small ears 4/13 2/4 6/17 (35)
Large ears 1/13 0/4 1/17 (6)
Thickened ear helices 7/13 1/2 8/15 (53)
Ear-pinna dysplasia 3/13 1/1 4/14 (29)
Ear asymmetry 7/13 1/1 8/14 (57)
Low-set ear(s) 6/13 4/4 10/17 (59)
Posteriorly rotated ear(s) 3/13 0/4 3/17 (18)
Short palpebral ﬁssures 3/13 2/4 5/17 (29)
Palpebral ﬁssures (up) 6/13 1/4 7/17 (41)
Palpebral ﬁssures (down) 4/13 2/4 6/17 (35)
Deep-set eyes 6/13 1/1 7/14 (50)
Hypotelorism 4/13 0/0 4/13 (31)
Hypertelorism (apparent) 2/13 0/0 2/13 (15)
Flat nasal bridge 9/13 2/4 11/17 (65)
Flat nose 5/13 0/1 5/14 (36)
High nasal bridge 3/13 1/1 4/14 (29)
Long-appearing philtrum 4/13 0/4 4/17 (24)
Prognathism 3/8 1/1 4/9 (44)
Pointed chin 10/13 2/2 12/15 (80)
Small hands/feet 1/13 2/2 3/15 (20)
Fifth ﬁnger short/clinodactyly 8/13 1/1 9/14 (64)
Scrotal hypoplasia 1/6 0/1 1/7 (14)
Congenital:
CT/MRI anomalyc 2/10 0/1 2/11 (18)
Cleft lip/palate 2/13 0/5 2/18 (11)
Infantile cardiomyopathy 2/6 2/3 4/9 (44)
Congenital heart defect (minor) 2/13 1/5 3/18 (17)
Cryptorchidism 1/6 1/1 2/7 (29)
NOTE.—Data are proportion or percentage of patients in whom the feature either could be directly
assessed or was speciﬁcally noted in a clinical report.
a Includes hand biting, banging or throwing objects, striking people, and episodes of violent physical
activity.
b Includes simple and complex partial seizures, myoclonus, and infantile spasms (modiﬁed hypsarrhyth-
mia).
c Includes lateral ventricle asymmetry, ventricular enlargement, and focal atrophy.
(except patient 3, in whom heterozygosity for a Web (1997) resources (http://www.med.upenn.edu/
Çponcol/chr1/resources.html) and from radiation-marker was used to indicate lack of deletion). The
marker order on the genetic map was based on map- hybrid mapping data for 1p35-36 (Jensen et al.,
1997).ping data obtained from Chromosome 1 World Wide
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the results are summarized in table 2, along with the
age at diagnosis and the indication for referral for cyto-
genetic studies. Partial G-banded karyotypes showing
pairs of chromosomes 1 from several deletion patients
are shown in ﬁgure 2A. Cytogenetic studies of the moth-
ers (n Å 14) and available fathers (n Å 9), in conjunction
with FISH using probes p1-79 and p58, showed no rear-
rangements involving distal 1p for the parents of 13 of
the 14 patients. The one exception was the father of
patient 13, who was found to carry a presumed balanced
translocation with breakpoints in 1p36.2 and 22q13.3.
Metaphase cells from the 14 patients with 1p36 dele-
tions were analyzed by FISH using probes p1-79, p58,
1A9, and 13P11; a representative example of the FISH
analysis for 1 patient is shown in ﬁgure 2B. All 14 pa-
tients were deleted for probe p58, 13 of 14 patients were
deleted for probe p1-79, 5 of 14 patients were deleted
for probe 1A9, and 2 of 14 patients were deleted for
probe 13P11 (results are summarized in ﬁg. 3). Patient 4
(not deleted for p1-79) is presumed to have an interstitial
deletion, within 1p36.3, that preserves the more
telomeric region of the chromosome (containing p1-79)
but that still deletes the region containing p58. These
results from patient 4 suggest that p1-79 is distal to p58
on chromosome 1.
Molecular Polymorphism Analysis of 1p36 Deletion
Figure 1 Patients with chromosome 1p36 deletions. Panel num- Syndrome Patients
bers in the upper-left-hand corners are patient numbers. Frontal views
Between 6 and 12 dinucleotide- and tetranucleotide-are shown for all patients, and lateral views are shown for patients
13 and 14. repeat polymorphic markers that map to distal 1p36
were examined for each family. Representative results
of markers analyzed for families 8 and 9 are shown in
ﬁgure 4. A summary of the results of the marker analysesResults
is shown in ﬁgure 3. A signiﬁcant difference in parental
Clinical Features of 1p36 Deletion Patients origin of the de novo–deleted chromosome 1 was ob-
The 14 patients with 1p36 deletion are shown in ﬁg- served with 17% paternally derived and 83%maternally
ure 1. Patient 13 has a presumed double-segmental im- derived deletions (x21 Å 5.3, .01 õ P õ .05). On the
balance (1p36 monosomy and minimal 22q13.3 tri- basis of the polymorphic marker and FISH results, the
somy) and is not included in the clinical characterization size of the deletion region was found to vary between
of pure 1p36 deletions. The frequencies of clinical fea- the patients. By combining the FISH analyses using
tures of the remaining 13 patients are listed in table 1, probes p1-79, p58, 1A9, and 13P11 with the polymor-
along with data from reports describing 5 other patients phic marker analyses, the deletions could be arrayed,
with similar single-segmental imbalances: 4 individuals with many patients having deletions of different size but
with 1p36 deletions (Keppler-Noreuil et al. 1995; Reish all of them containing a minimal deletion interval, in
et al. 1995) and 1 individual with a 1p35 deletion distal 1p36, that encompassed marker D1S243 and
(Wenger et al. 1988). Patients with pure 1p36 deletions probe p58 (ﬁg. 3). On the basis of the markers used in
reported by others in abstracts alone (Magenis et al. the present study, patient 4 appeared to have the small-
1987; Wargowski et al. 1991; Wexler et al. 1991; est deletion, and patient 13 had the largest deletion.
Sandlin et al. 1995) were not included in this compari-
son, because of lack of a complete phenotypic descrip- Discussion
tion and photographs.
Thirteen patients with pure chromosome 1p36 dele-
Cytogenetic and FISH Analyses of 1p36 Deletion tions have been evaluated for their clinical phenotypes
Syndrome Patients (table 1). These 13 patients with single-segmental imbal-
ance, as well as 1 patient with a double-segmental imbal-The 1p36 deletions in the 14 patients were ascertained
by 600–800-band–resolution cytogenetic analysis, and ance (patient 13), have been evaluated for the size and
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Table 2
Cytogenetic Analysis of 1p36 Deletion Patients
Patient Age at Diagnosis Referral Indication Karyotype
1 11 years 3 mo Developmental delay; dysmorphism 46,XY,del(1)(p36.22)
2 10 years 9 mo Developmental delay; dysmorphism 46,XX,del(1)(p36.2)
3 4 years 10 mo Developmental delay; dysmorphism 46,XY,del(1)(p36.2)
4 5 years 11 mo Possible Prader-Willi syndrome 46,XX,del(1)(p36.31)
5 2 years 9 mo Seizures; developmental delay 46,XY,del(1)(p36.23)
6 2 years 9 mo Developmental delay; growth delay 46,XX,del(1)(p36.2)
7 2 years 2 mo Developmental delay 46,XY,del(1)(p36.2)
8 Prenatal Abnormal maternal serum alpha-fetoprotein 46,XX,del(1)(p36.22)
9 2 wk Seizures 46,XX,del(1)(p36.2)
10 4 d Dysmorphic features 46,XY,del (1)(p36.2)
11 10 years 1 mo Possible Rubinstein-Taybi syndrome 46,XX,del(1)(p36.22)
12 4 d Multiple congenital anomalies 46,XY,del(1)(p36.2)
13 7 mo Seizures; dysmorphism 46,XY,der(1)t(1;22)(p36.2;q13.3)pat
14 6 mo Multiple congenital anomalies 46,XX,del(1)(p36.2)
parental origin of their deletions (ﬁg. 3). Cytogenetic segmental imbalance. Although the fathers of ﬁve of the
patients were not available for testing by cytogeneticand molecular studies have determined that, in the 13
patients with pure 1p36 deletions, the deletions are de analysis or FISH in order to exclude a paternal translo-
cation, in each of these cases the origin of the deletednovo and do not appear to include other chromosomal
chromosome was found, by molecular studies, to be
maternal, thus conﬁrming that each deletion was a de
novo event. The patients reported here represent a useful
resource for delineation of the clinical phenotype, be-
cause they represent a substantial cohort of pure single-
segmental imbalance for 1p36 deletions. Patient 13
(with presumed double-segmental imbalance), who was
excluded from the clinical characterization of the syn-
drome (table 1) but was included in the molecular stud-
ies (ﬁg. 3), is of interest because, by cytogenetic and
FISH analysis, he appeared to have a pure 1p36 deletion.
However, only after the cytogenetic and FISH studies
performed on his parents identiﬁed his father as a trans-
location carrier was the cytogenetic interpretation for
him changed to 46,XY,der(1)t(1;22)(p36.2;q13.3)pat.
Therefore, it is prudent to perform cytogenetic and FISH
evaluation of the parents of all 1p36 deletion patients,
in order to exclude the possibility that a patient has
an unbalanced-translocation product inherited from a
parent who carries a balanced translocation.
The 1p36 deletion syndrome appears to be more com-
mon than most other deletion syndromes. Population
studies have shown that, for other deletion syndromes,
the incidence is estimated to be 1/45,000 for 5p mono-
somy (Niebuhr 1978), 1/25,000 for Prader-Willi syn-
drome (Butler 1990), and §1/4,000 for the 22q11 dele-Figure 2 Cytogenetic analysis and FISH analysis for 1p36 dele-
tion involved in DiGeorge/velo-cardio-facial syndrometions. A, Ideogram of chromosome 1p and pairs of chromosome 1
(Burn et al. 1995). With regard to the incidence of 1p36from several deletion patients. For each pair, the deleted chromosome
1 is on the right. From left to right, the pairs of chromosome 1 corre- deletion syndrome, six of our patients were born in 1996
spond to patients 10, 10, 11, 9, 4, and 8. B, FISH analysis from patient in Harris County (Texas), where there are Ç60,000
11 is shown; both the normal (nl) and deleted (del) chromosome 1 births/year (Texas Department of Health 1995 statis-show hybridization with the control probe at the centromere (D1Z5),
tics). Therefore, the incidence of monosomy 1p36 ap-but one chromosome (del 1) of the pair is deleted for the distal 1p36
probe, p1-79. pears to beú1/10,000, since it is likely that not all cases
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Figure 3 Natural 1p36 deletion panel, for 14 patients, from analysis of microsatellite markers and FISH probes. Polymorphic markers
and FISH probes are listed at the left, in order, from distal (top) to proximal in chromosome 1p36. The 14 deletion patients are listed at the
top of the ﬁgure, over each deletion panel. The deletion size decreases from left to right. Beneath each deletion panel is an indication of whether
the deletion is paternally derived (P) or maternally derived (M). Since parental samples were not available for the analysis of patient 3, the
indicated deleted regions were determined by analysis with FISH probes, and the nondeleted regions were inferred from heterozygosity for the
microsatellite markers.
in the catchment area have yet been ascertained. This
estimate may seem high, but 1p36 deletions are likely
being underascertained in most cytogenetics labora-
tories. Of our 14 patients, 6 had prior cytogenetic stud-
ies in which the deletion was not identiﬁed. Three of
these six patients had their initial cytogenetic study per-
formed in 1996 (one in each of three different cytogenet-
ics laboratories), and two of these three patients (13 and
14) have large deletions that were not detected in the
initial cytogenetic studies.
For individuals with monosomy for 1p36, moderate
to severe mental retardation, hypotonia, and develop-
mental delay are found almost universally. Full-scale IQ
scores are generally õ60 (on the basis of testing per-
formed on our six oldest patients; the other patients
were too young for adequate testing). Although gross
and ﬁne motor skills are moderately delayed, speech
Figure 4 Polymorphic marker analysis for 1p36 deletion pa- development is more signiﬁcantly impaired. The vast
tients. Fully informative analyses of two chromosome 1p36 markers majority (85%) of individuals have signiﬁcant growth
are shown for patients 8 and 9 and their parents. Patient 9 demon- retardation. However, several reports note that a few
strates inheritance of only one allele (from her father) for marker
individuals had infantile feeding problems and poorD1S468 and therefore has a deletion for this marker on the maternally
weight gain but developed obesity and/or macrosomiaderived chromosome. At locus D1S548, patient 9 is heterozygous,
since she has inherited a different allele from each parent, indicating in childhood, like patients with Prader-Willi syndrome
no deletion for this marker. Patient 8 has a deletion on the paternally (Wenger et al. 1988; Wargowski et al. 1991; Keppler-
derived chromosome, since she has inherited only one allele (from her Noreuil et al. 1995); in each of these cases, the diagnosis
mother) for marker D1S243. Patient 8 is heterozygous for the marker
of Prader-Willi syndrome was suggested before the cor-FGR, indicating no deletion for this marker. Marker FGR, although
rect cytogenetic diagnosis of monosomy 1p36 wasanalyzed for many of the patients, is not shown in ﬁgure 3 because it
maps outside the deletion region. made. Previous reports (Wargowski et al. 1991; Kep-
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pler-Noreuil et al. 1995; Sandlin et al. 1995) have sug- also suggested that congenital heart defects and cardio-
myopathy are common features of this deletion syn-gested that two distinct clinical phenotypes constitute
this deletion syndrome: (1) growth failure associated drome, but we did not ﬁnd congenital heart defects to
be common in our cohort. Two of our patients (patientswith hirsutism, speciﬁc craniofacial features (small face,
midface hypoplasia, short up-slanting palpebral ﬁssures, 12 and 14) had infantile cardiomyopathy, and none of
our patients had signiﬁcant congenital heart defects (oneepicanthal folds, deep-set eyes, small nose, and micro-
gnathia), and cleft lip and/or cleft palate and (2) normal had a patent ductus arteriosus, and one had mild left-
pulmonary-artery-branch stenosis). Other reports havegrowth parameters or obesity associated with other cra-
niofacial features (tall forehead, broad face, bitemporal described patients with infundibular stenosis, tetralogy
of Fallot, and ventricular septal defects (Yunis et al.narrowing, normal palpebral ﬁssures, hypertelorism,
sparse eyebrows, ﬂat nasal bridge, broad nasal root, and 1981; Magenis et al. 1987; Biegel et al. 1993), but in
the ﬁrst case there was other chromosomal segmentalprominent jaw or prognathism). Our experience, based
on detailed clinical assessment of the 14 patients re- imbalance, and in the other two cases the deletion
breakpoints were judged to be more proximal (1p36.13ported here, is that each of the craniofacial features of
these two supposed clinical phenotypes occurs in a pro- and 1p36.1, respectively) than those in the patients de-
scribed here. Therefore, we do not consider signiﬁcantportion of the patients but that these features do not
separate the patients into two distinguishable groups. In cardiac defects to be a common feature of this deletion
syndrome. However, infantile cardiomyopathy occurredaddition, it does not appear that differing craniofacial
features are due to the size of the chromosomal deletion. in two of our patients, as well as in two other patients
with pure 1p36 deletions (Keppler-Noreuil et al. 1995),Patients with both small and large deletions may have
very similar craniofacial features (compare patients 4 and may occur in £44% of patients.
It has been suggested that cleft lip or cleft lip/palateand 9 [ﬁg. 1], who have developed a closer resemblance
as patient 9 has grown older), whereas patients with occurs in £40% of patients with this condition (Kep-
pler-Noreuil et al. 1995). Two of our patients hadsimilar-size deletions may have quite different pheno-
types (compare patients 1 and 2 [ﬁg. 1], whose photo- clefting defects (patient 14 had cleft lip, and patient 12
had cleft lip/palate), which suggests a lower incidencegraphs were obtained at the same age). The phenotypic
variability among these patients may represent ethnic (closer to 10%) for this congenital anomaly.
Although there is clinical variability between the pa-differences, may reﬂect natural variation in the genetic
background, or may be associated with deletion of spe- tients with the 1p36 deletion syndrome, this condition
has a recognizable phenotype that is unique enough tociﬁc regions of the genetic map.
At birth, all of our patients had normal measurements consider it as a newly delineated syndrome; in our pa-
tient series, the diagnosis was made by the geneticistfor weight, length, and head circumference, but the vast
majority (85%) became growth retarded at ageú1 year. and/or neurologist, on the basis of clinical examina-
tion, before the cytogenetic result was available, forSeveral older patients had normal growth parameters at
the time of ascertainment (in our series, patients 2 and patients 11–14; the other 10 patients were diagnosed
retrospectively after chromosome analysis (except for11), and a few patients had infantile feeding problems
but developed childhood obesity similar to what occurs patient 8, who was diagnosed by prenatal testing). The
prospective diagnosis for patients 11–14 was possiblein Prader-Willi syndrome (in our series, patient 4). The
two older patients with normal growth parameters at because each patient had many of the most common
features listed in table 1, as well as having had somethe time of ascertainment (both of whom were girls 10–
11 years of age) previously had been õ3d centile for of the other less common features (i.e., cleft lip/palate,
infantile cardiomyopathy, and infant feeding prob-height and weight but subsequently had early pubertal
growth spurts that increased their height and weight to lems). On the basis of the clinical assessments of our
entire patient cohort and those reviewed in the litera-the normal range. As these two patients are followed, it
is expected that they will complete puberty early (they ture who have single-segmental imbalance, we suggest
that the most common features that constitute this dele-are already Tanner IV–V at age 10–11 years and started
menses at age 10 years), plateau in their growth, and tion syndrome include large anterior fontanelle
(100%), motor delay/hypotonia (92%), moderate toattain adult heights that are õ3d centile. Thus, the cate-
gory of patients with ‘‘normal growth’’ or obesity may in severe mental retardation (92%), growth delay (85%),
pointed chin (80%), eye/vision problems (75%), sei-fact represent hypothalamic/pituitary dysfunction that
manifests as precocious puberty in some patients and zures (72%), ﬂat nasal bridge (65%), clinodactyly and/
or short ﬁfth ﬁnger(s) (64%), low-set ear(s) (59%), earas obesity in others. We did not observe a correlation
between these growth anomalies and particular cranio- asymmetry (57%), hearing deﬁcits (56%), abusive be-
havior (56%), thickened ear helices (53%), and deep-facial features, as has been suggested in other reports
(Keppler-Noreuil et al. 1995). set eyes (50%). All other craniofacial features occur in
õ50% of the patients and do not separate into consis-Previous reports (Keppler-Noreuil et al. 1995) have
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Chester Brown, Ian Butler, William Craigen, Marvin Fishman,tent patterns of anomalies. Eye/vision problems among
Gisele Greenhaw, Jacqueline Hecht, Katherine Hegmann, Gailour patients include strabismus, 6th-nerve palsy, am-
Herman, William Horton, Stefan Kochanek, Michael Levin,blyopia, refractive errors (including hyperopia, myo-
Avi Orr-Urtreger, Diana Rodriguez, Helen Ross, David Stock-pia, and/or astigmatism), anomalous optic disks, and
ton, and Elaine Wendt. We thank Kay Atkins and Jill Johnstonlacrimal defects. Hearing deﬁcits include both conduc-
(Kleberg Cytogenetics Laboratory) and Wilbur Harrison (Her-
tive and sensorineural abnormalities. Seizures occur in mann Hospital Cytogenetics Laboratory) for FISH analysis of
infancy in more than two-thirds of patients but have the patients and their parents. We thank John Bargerstock and
two patterns of clinical outcome. One group of patients Stella Madu in the Mental Retardation Research Center tissue-
has a few seizures in infancy, with normal electroen- culture core (Baylor College of Medicine) for establishing
cephalograms (EEGs), that may receive transient ther- lymphoblastoid cell lines. We thank Dr. Peter S. White (Chil-
dren’s Hospital of Philadelphia) for providing information onapy with anticonvulsants, but has no recurrence of the
marker order in distal 1p36, on the basis of radiation-hybridseizures at age ú1 year (in our series, patients 1, 4, 8,
mapping, and for useful discussions. We are grateful to theand 10). The other group of patients also has infantile
families for participating in these studies.seizures, but these patients have abnormal EEGs and
require anticonvulsants for treatment of chronic sei-
zures (in our series, patients 5, 9, and 11–14). References
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